Aclarion (ACON) said Monday Scripps Health will add its Nociscan technology platform to help find sources of chronic low back pain at Scripps facilities in San Diego area.

Shares surged 123% as intraday trading volume soared to more than 69 million shares from a daily average of about 646,000.

BioXcel Therapeutics (BTAI) said Monday that the US Food and Drug Administration has concluded that the inspection of a single site in its TRANQUILITY II Phase 3 trial is closed.

The company said the conclusion further supports reliability of data from the trial of BXCL501.

Shares more than doubled as trading volume catapulted to over 138 million from a daily average of about 1.91 million.

Allegro MicroSystems (ALGM) shares soared 17% after Bloomberg reported Sunday ON Semiconductor (ON) is working on a potential acquisition of Allegro.

Over 7.3 million shares traded intraday versus a daily average of roughly 2.45 million.

Price: 8.44, Change: +5.09, Percent Change: +151.88